JLHL Q4 FY26 Earnings Call Transcript & Analysis
Revenue (Q4 FY26) ₹388 cr (+15% YoY); EBITDA (FY26) ₹343 cr (+14% YoY); EBITDA Margin (FY26) 22.9%. FY26 Total Income of ₹1,499.8 crores, up 15.2% YoY.
Read full transcript & analysis
Every earnings call for JLHL — management tone, guidance, KPIs and promise tracking, quarter by quarter.
JLHL · 6 transcripts · Healthcare · latest Q4 FY26Revenue (Q4 FY26) ₹388 cr (+15% YoY); EBITDA (FY26) ₹343 cr (+14% YoY); EBITDA Margin (FY26) 22.9%. FY26 Total Income of ₹1,499.8 crores, up 15.2% YoY.
Read full transcript & analysisEBITDA (Q3 FY26) ₹83 cr (+9% YoY); EBITDA Margin (Q3 FY26) 22.8%; PAT (Q3 FY26) ₹42 cr (−19% YoY). Dombivli hospital completed ahead of schedule and within budget (INR 425 crores capex).
Read full transcript & analysisQ2 Operating Income ₹374 cr (+12% YoY); Q2 EBITDA ₹85 cr (+9% YoY); Q2 EBITDA Margin 22.8%. Q2 FY26 Operating Income: ₹374.4 crores, up 11.7% YoY.
Read full transcript & analysisEBITDA ₹78 cr (+20% YoY); EBITDA Margin 22.5%. Total income grew 20.5% YoY to ₹347.6 crores.
Read full transcript & analysisEBITDA (FY25) ₹297 cr (+22% YoY); EBITDA Margin (FY25) 23.5%; PAT (FY25) ₹194 cr. FY25 Income of ₹1,261.5 crores, up 17.5% YoY.
Read full transcript & analysisEBITDA (Q3 FY25) ₹76 cr (+22% YoY); EBITDA Margin (Q3 FY25) 23.7%; PAT (Q3 FY25) ₹52 cr (+20% YoY). Q3 FY25 Income grew 17.7% YoY to Rs. 322 crores.
Read full transcript & analysis